Gartner Falls 13% on Earnings Day as Shorts Creep Back

Gartner reported Q3 results on November 3, and the market's reaction was immediate and severe. The stock dropped 13.2% on the day, pulling its weekly loss to 7.6%, while the median peer in its closest comparable group gained 1.7% over the same period. Cognizant fell 3.6% on the week, and Accenture gained 8.2%, making Gartner's underperformance look even sharper in context.

Short interest has begun rebuilding after the covering wave documented heading into the print. Shares short rose 2.1% on November 3 alone and are up 2.5% over the week, bringing the total back to 6.87 million shares, equal to 9.5% of the free float. That is a meaningful level for any name, though it remains well below the early-October peak of roughly 8 million shares. The borrow market remains loose: availability at 1,257% means there are still more than 12 shares available to lend for every one currently borrowed, so there is no structural squeeze pressure. Cost to borrow has climbed to 0.62%, a 15% rise over the week and 38% over the past month. The absolute level is still low, but the direction has changed, and bears building new positions are paying more than they were a month ago.

The analyst response to Q3 has been swift and mixed. Morgan Stanley's Toni Kaplan raised the price target from $182 to $192, keeping an Equal-Weight rating. Goldman Sachs lifted its target from $181 to $207, also at Neutral. The move that changes the story is Truist Securities downgrading from Buy to Hold, cutting the target from $235 to $210, all on the same morning the results dropped. Wells Fargo, already at Underweight, raised its target from $150 to $175 but stayed negative. The mean consensus target now stands at $197.77, actually below the pre-earnings close, leaving no implied upside at the post-earnings price of $204.22. The bears at Truist point to slowing IT spending, Federal contract headwinds and disintermediation risk from generative AI eating into Gartner's advisory franchise. Bulls, including Goldman, credit the subscription model, high client retention and a $200 billion total addressable market. EV/EBITDA has contracted sharply, dropping 1.3 turns over the past month to 8.8x, while the price-to-earnings multiple has also eased to 12.6x. Gartner's earnings yield factor ranks in the 78th percentile and EV/EBIT in the 74th, suggesting the valuation is now more interesting than it was a week ago even after the selloff, but the earnings momentum scores, in the mid-40s to low-50s, offer little near-term fundamental cover.

Options positioning turned more bullish in the days running into the print. The put/call ratio at 0.62 is roughly 1.1 standard deviations below its 20-day average of 0.69. That is the flipside of the Truist downgrade: options traders were leaning bullish into results while one of the most recent buyers on the analyst desk just turned neutral. Wikipedia page views carried a z-score of 2.2 against the previous 90 days as of October 22, pointing to elevated retail attention in the run-up. That attention has now met a 13% one-day drop.

Baron Capital remains the largest institutional holder, reporting 7.6 million shares, or 12% of the company, as of September 30, having added 1.68 million shares in the quarter. Independent Franchise Partners held 5.58 million shares as of June 30, adding nearly a million. On the activist register there is no Schedule 13D holder: all filers are passive 13G. The Vanguard Group's most recent 13G/A, filed in March, showed a position that had fallen to zero from 12.43%, a notable reduction, though the positions from Vanguard Capital Management and Vanguard Portfolio Management, filed in April, show fresh stakes of 7.32% and 5.26% respectively. These disclosures are as-filed and positions may have changed. Insider activity in the 90 days to October 15 resulted in a net sale of 7,082 shares valued at roughly $1.37 million, though the recent Form 4 filings are almost entirely compensation mechanics, options exercises and tax withholding, with no open-market purchases or sales of note.

The next earnings event is scheduled for February 2, 2027. Between now and then, the question is whether the analyst target resets following today's earnings pull lower than the current price, combined with short interest resuming its rebuild, represents a new equilibrium or the start of a more sustained downward re-rating.